Effect of modafinil on fatigue associated with neurological illnesses

Journal of Chronic Fatigue Syndrome

Volumn 8, Issue 2, 2001, Pages 65-70

  Cochran, J W ^a  

^a Eberly and Howe   (United States)

Author keywords

Alzheimer's disease; Fatigue; Modafinil; Neurological illnesses, stroke

Indexed keywords

MODAFINIL;

ALZHEIMER DISEASE; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG TOLERANCE; HUMAN; NEUROLOGIC DISEASE; PARKINSON DISEASE; STROKE;

EID: 0035200592     PISSN: 10573321     EISSN: None     Source Type: Journal    
DOI: 10.1300/J092v08n02_06     Document Type: Article

References (16)

1. Chronic fatigue syndrome: An update
2. The impact of fatigue on patients with multiple sclerosis
3. Amantadine therapy for fatigue in multiple sclerosis
4. Fatigue in patients with Parkinson's disease
5. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat
6. Modafinil: An antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers
7. Hypothalamic arousal regions are activated during modafinil-induced wakefulness
8. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy
9. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
10. Modafinil in obstructive sleep apnea-hypopnea syndrome: A pilot study in 6 patients
11. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil
12. Naps and modafinil as countermeasures for the effects of sleep deprivation on cognitive performance
13. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. II. Effects on two nights of recovery sleep
14. PROVIGIL (Modafinil): Efficacy for the treatment of fatigue in patients with multiple sclerosis
15. Fatigue in multiple sclerosis. Evaluation and a New Pharmacological Approach
16. Modafinil augmentation of antidepressant treatment in depression